nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—migraine—Prednisone—hematologic cancer	0.283	1	CpDpCtD
Sumatriptan—ABCG2—hematologic cancer	0.132	0.706	CbGaD
Sumatriptan—ABCB1—hematologic cancer	0.055	0.294	CbGaD
Sumatriptan—SLCO1A2—Chlorambucil—hematologic cancer	0.0313	0.0998	CbGbCtD
Sumatriptan—ABCG2—Clofarabine—hematologic cancer	0.0283	0.0902	CbGbCtD
Sumatriptan—ABCG2—Daunorubicin—hematologic cancer	0.0166	0.0529	CbGbCtD
Sumatriptan—ABCG2—Teniposide—hematologic cancer	0.0144	0.046	CbGbCtD
Sumatriptan—ABCG2—Cladribine—hematologic cancer	0.0138	0.0441	CbGbCtD
Sumatriptan—ABCG2—Imatinib—hematologic cancer	0.0127	0.0405	CbGbCtD
Sumatriptan—SLCO1A2—Prednisolone—hematologic cancer	0.0118	0.0377	CbGbCtD
Sumatriptan—ABCG2—Nilotinib—hematologic cancer	0.0116	0.0368	CbGbCtD
Sumatriptan—SLCO1A2—Prednisone—hematologic cancer	0.0112	0.0356	CbGbCtD
Sumatriptan—ABCG2—Dasatinib—hematologic cancer	0.0102	0.0325	CbGbCtD
Sumatriptan—ABCB1—Lenalidomide—hematologic cancer	0.0102	0.0325	CbGbCtD
Sumatriptan—ABCG2—Mitoxantrone—hematologic cancer	0.0101	0.0321	CbGbCtD
Sumatriptan—SLCO1B1—Irinotecan—hematologic cancer	0.01	0.0319	CbGbCtD
Sumatriptan—ABCG2—Irinotecan—hematologic cancer	0.00795	0.0253	CbGbCtD
Sumatriptan—SLCO1A2—Dexamethasone—hematologic cancer	0.00698	0.0222	CbGbCtD
Sumatriptan—ABCG2—Vincristine—hematologic cancer	0.00695	0.0221	CbGbCtD
Sumatriptan—ABCG2—Cisplatin—hematologic cancer	0.00648	0.0206	CbGbCtD
Sumatriptan—ABCG2—Etoposide—hematologic cancer	0.00637	0.0203	CbGbCtD
Sumatriptan—ABCB1—Daunorubicin—hematologic cancer	0.00599	0.0191	CbGbCtD
Sumatriptan—ABCB1—Alitretinoin—hematologic cancer	0.00587	0.0187	CbGbCtD
Sumatriptan—SLCO1A2—Methotrexate—hematologic cancer	0.00561	0.0179	CbGbCtD
Sumatriptan—SLCO1B1—Methotrexate—hematologic cancer	0.0053	0.0169	CbGbCtD
Sumatriptan—ABCG2—Dexamethasone—hematologic cancer	0.00524	0.0167	CbGbCtD
Sumatriptan—ABCB1—Imatinib—hematologic cancer	0.00459	0.0146	CbGbCtD
Sumatriptan—ABCG2—Doxorubicin—hematologic cancer	0.00434	0.0138	CbGbCtD
Sumatriptan—ABCG2—Methotrexate—hematologic cancer	0.00421	0.0134	CbGbCtD
Sumatriptan—ABCB1—Nilotinib—hematologic cancer	0.00417	0.0133	CbGbCtD
Sumatriptan—ABCB1—Vinorelbine—hematologic cancer	0.00414	0.0132	CbGbCtD
Sumatriptan—ABCB1—Dasatinib—hematologic cancer	0.00369	0.0117	CbGbCtD
Sumatriptan—ABCB1—Mitoxantrone—hematologic cancer	0.00364	0.0116	CbGbCtD
Sumatriptan—ABCB1—Betamethasone—hematologic cancer	0.00325	0.0103	CbGbCtD
Sumatriptan—ABCB1—Gemcitabine—hematologic cancer	0.00322	0.0102	CbGbCtD
Sumatriptan—ABCB1—Prednisolone—hematologic cancer	0.0032	0.0102	CbGbCtD
Sumatriptan—ABCB1—Prednisone—hematologic cancer	0.00302	0.00963	CbGbCtD
Sumatriptan—ABCB1—Irinotecan—hematologic cancer	0.00287	0.00913	CbGbCtD
Sumatriptan—ABCB1—Vinblastine—hematologic cancer	0.00255	0.00811	CbGbCtD
Sumatriptan—ABCB1—Vincristine—hematologic cancer	0.00251	0.00798	CbGbCtD
Sumatriptan—ABCB1—Cisplatin—hematologic cancer	0.00234	0.00744	CbGbCtD
Sumatriptan—ABCB1—Etoposide—hematologic cancer	0.0023	0.00731	CbGbCtD
Sumatriptan—ABCB1—Dexamethasone—hematologic cancer	0.00189	0.00601	CbGbCtD
Sumatriptan—ABCB1—Doxorubicin—hematologic cancer	0.00157	0.00499	CbGbCtD
Sumatriptan—ABCB1—Methotrexate—hematologic cancer	0.00152	0.00483	CbGbCtD
Sumatriptan—Melatonin—CALR—hematologic cancer	0.00117	0.706	CrCbGaD
Sumatriptan—HTR3A—hematopoietic system—hematologic cancer	0.000362	0.0861	CbGeAlD
Sumatriptan—SLCO1B1—hematopoietic system—hematologic cancer	0.000351	0.0835	CbGeAlD
Sumatriptan—SLCO1A2—hematopoietic system—hematologic cancer	0.000286	0.068	CbGeAlD
Sumatriptan—HTR1A—hematopoietic system—hematologic cancer	0.000245	0.0583	CbGeAlD
Sumatriptan—HTR3A—blood—hematologic cancer	0.00024	0.0571	CbGeAlD
Sumatriptan—SLCO1B1—blood—hematologic cancer	0.000233	0.0553	CbGeAlD
Sumatriptan—Melatonin—MPO—hematologic cancer	0.00023	0.139	CrCbGaD
Sumatriptan—MAOA—hematopoietic system—hematologic cancer	0.000224	0.0533	CbGeAlD
Sumatriptan—HTR3A—lung—hematologic cancer	0.00021	0.05	CbGeAlD
Sumatriptan—Melatonin—ESR1—hematologic cancer	0.000172	0.104	CrCbGaD
Sumatriptan—SLCO1A2—lung—hematologic cancer	0.000166	0.0395	CbGeAlD
Sumatriptan—SLCO1A2—testis—hematologic cancer	0.000157	0.0373	CbGeAlD
Sumatriptan—MAOA—blood—hematologic cancer	0.000148	0.0353	CbGeAlD
Sumatriptan—MAOA—lung—hematologic cancer	0.00013	0.0309	CbGeAlD
Sumatriptan—DRD2—lung—hematologic cancer	0.000129	0.0306	CbGeAlD
Sumatriptan—ABCG2—blood—hematologic cancer	0.000129	0.0306	CbGeAlD
Sumatriptan—ABCG2—bone marrow—hematologic cancer	0.000125	0.0296	CbGeAlD
Sumatriptan—MAOA—testis—hematologic cancer	0.000123	0.0292	CbGeAlD
Sumatriptan—DRD2—testis—hematologic cancer	0.000121	0.0289	CbGeAlD
Sumatriptan—ABCG2—lung—hematologic cancer	0.000113	0.0268	CbGeAlD
Sumatriptan—ABCG2—testis—hematologic cancer	0.000106	0.0253	CbGeAlD
Sumatriptan—ABCB1—hematopoietic system—hematologic cancer	9.58e-05	0.0228	CbGeAlD
Sumatriptan—MAOA—lymph node—hematologic cancer	8.9e-05	0.0212	CbGeAlD
Sumatriptan—Eletriptan—ABCB1—hematologic cancer	8.44e-05	0.051	CrCbGaD
Sumatriptan—ABCG2—lymph node—hematologic cancer	7.72e-05	0.0183	CbGeAlD
Sumatriptan—ABCB1—gonad—hematologic cancer	7.28e-05	0.0173	CbGeAlD
Sumatriptan—ABCB1—blood—hematologic cancer	6.35e-05	0.0151	CbGeAlD
Sumatriptan—ABCB1—bone marrow—hematologic cancer	6.14e-05	0.0146	CbGeAlD
Sumatriptan—ABCB1—lung—hematologic cancer	5.56e-05	0.0132	CbGeAlD
Sumatriptan—ABCB1—testis—hematologic cancer	5.25e-05	0.0125	CbGeAlD
Sumatriptan—ABCB1—lymph node—hematologic cancer	3.81e-05	0.00905	CbGeAlD
Sumatriptan—Fatigue—Dexamethasone—hematologic cancer	9.16e-06	5.66e-05	CcSEcCtD
Sumatriptan—Fatigue—Betamethasone—hematologic cancer	9.16e-06	5.66e-05	CcSEcCtD
Sumatriptan—Chills—Epirubicin—hematologic cancer	9.14e-06	5.65e-05	CcSEcCtD
Sumatriptan—Pruritus—Etoposide—hematologic cancer	9.14e-06	5.65e-05	CcSEcCtD
Sumatriptan—Shock—Prednisone—hematologic cancer	9.11e-06	5.63e-05	CcSEcCtD
Sumatriptan—Arrhythmia—Epirubicin—hematologic cancer	9.1e-06	5.63e-05	CcSEcCtD
Sumatriptan—Pain—Dexamethasone—hematologic cancer	9.09e-06	5.62e-05	CcSEcCtD
Sumatriptan—Pain—Betamethasone—hematologic cancer	9.09e-06	5.62e-05	CcSEcCtD
Sumatriptan—Visual impairment—Doxorubicin—hematologic cancer	9.08e-06	5.62e-05	CcSEcCtD
Sumatriptan—Nervous system disorder—Prednisone—hematologic cancer	9.08e-06	5.61e-05	CcSEcCtD
Sumatriptan—Tachycardia—Prednisone—hematologic cancer	9.03e-06	5.58e-05	CcSEcCtD
Sumatriptan—Skin disorder—Prednisone—hematologic cancer	8.99e-06	5.56e-05	CcSEcCtD
Sumatriptan—Nausea—Gemcitabine—hematologic cancer	8.98e-06	5.55e-05	CcSEcCtD
Sumatriptan—Vomiting—Cisplatin—hematologic cancer	8.96e-06	5.54e-05	CcSEcCtD
Sumatriptan—Hyperhidrosis—Prednisone—hematologic cancer	8.95e-06	5.53e-05	CcSEcCtD
Sumatriptan—Rash—Cisplatin—hematologic cancer	8.89e-06	5.49e-05	CcSEcCtD
Sumatriptan—Dermatitis—Cisplatin—hematologic cancer	8.88e-06	5.49e-05	CcSEcCtD
Sumatriptan—Erythema—Epirubicin—hematologic cancer	8.87e-06	5.48e-05	CcSEcCtD
Sumatriptan—Diarrhoea—Etoposide—hematologic cancer	8.84e-06	5.46e-05	CcSEcCtD
Sumatriptan—Eye disorder—Doxorubicin—hematologic cancer	8.81e-06	5.45e-05	CcSEcCtD
Sumatriptan—Ill-defined disorder—Methotrexate—hematologic cancer	8.79e-06	5.44e-05	CcSEcCtD
Sumatriptan—Tinnitus—Doxorubicin—hematologic cancer	8.79e-06	5.43e-05	CcSEcCtD
Sumatriptan—Anaemia—Methotrexate—hematologic cancer	8.76e-06	5.41e-05	CcSEcCtD
Sumatriptan—Feeling abnormal—Dexamethasone—hematologic cancer	8.76e-06	5.41e-05	CcSEcCtD
Sumatriptan—Feeling abnormal—Betamethasone—hematologic cancer	8.76e-06	5.41e-05	CcSEcCtD
Sumatriptan—Flushing—Doxorubicin—hematologic cancer	8.75e-06	5.41e-05	CcSEcCtD
Sumatriptan—Flatulence—Epirubicin—hematologic cancer	8.74e-06	5.4e-05	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Dexamethasone—hematologic cancer	8.69e-06	5.37e-05	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Betamethasone—hematologic cancer	8.69e-06	5.37e-05	CcSEcCtD
Sumatriptan—Dysgeusia—Epirubicin—hematologic cancer	8.69e-06	5.37e-05	CcSEcCtD
Sumatriptan—Hypersensitivity—Triamcinolone—hematologic cancer	8.63e-06	5.33e-05	CcSEcCtD
Sumatriptan—Back pain—Epirubicin—hematologic cancer	8.58e-06	5.3e-05	CcSEcCtD
Sumatriptan—Angiopathy—Doxorubicin—hematologic cancer	8.55e-06	5.29e-05	CcSEcCtD
Sumatriptan—Malaise—Methotrexate—hematologic cancer	8.55e-06	5.28e-05	CcSEcCtD
Sumatriptan—Dizziness—Etoposide—hematologic cancer	8.54e-06	5.28e-05	CcSEcCtD
Sumatriptan—Muscle spasms—Epirubicin—hematologic cancer	8.53e-06	5.27e-05	CcSEcCtD
Sumatriptan—Immune system disorder—Doxorubicin—hematologic cancer	8.52e-06	5.26e-05	CcSEcCtD
Sumatriptan—Vertigo—Methotrexate—hematologic cancer	8.51e-06	5.26e-05	CcSEcCtD
Sumatriptan—Mediastinal disorder—Doxorubicin—hematologic cancer	8.5e-06	5.25e-05	CcSEcCtD
Sumatriptan—Chills—Doxorubicin—hematologic cancer	8.46e-06	5.23e-05	CcSEcCtD
Sumatriptan—Urticaria—Dexamethasone—hematologic cancer	8.44e-06	5.22e-05	CcSEcCtD
Sumatriptan—Urticaria—Betamethasone—hematologic cancer	8.44e-06	5.22e-05	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Prednisone—hematologic cancer	8.43e-06	5.21e-05	CcSEcCtD
Sumatriptan—Dizziness—Prednisolone—hematologic cancer	8.42e-06	5.21e-05	CcSEcCtD
Sumatriptan—Arrhythmia—Doxorubicin—hematologic cancer	8.42e-06	5.21e-05	CcSEcCtD
Sumatriptan—Asthenia—Triamcinolone—hematologic cancer	8.4e-06	5.19e-05	CcSEcCtD
Sumatriptan—Abdominal pain—Dexamethasone—hematologic cancer	8.4e-06	5.19e-05	CcSEcCtD
Sumatriptan—Abdominal pain—Betamethasone—hematologic cancer	8.4e-06	5.19e-05	CcSEcCtD
Sumatriptan—Body temperature increased—Dexamethasone—hematologic cancer	8.4e-06	5.19e-05	CcSEcCtD
Sumatriptan—Body temperature increased—Betamethasone—hematologic cancer	8.4e-06	5.19e-05	CcSEcCtD
Sumatriptan—Nausea—Cisplatin—hematologic cancer	8.37e-06	5.17e-05	CcSEcCtD
Sumatriptan—Paraesthesia—Prednisone—hematologic cancer	8.31e-06	5.14e-05	CcSEcCtD
Sumatriptan—Pruritus—Triamcinolone—hematologic cancer	8.29e-06	5.12e-05	CcSEcCtD
Sumatriptan—Cough—Methotrexate—hematologic cancer	8.27e-06	5.11e-05	CcSEcCtD
Sumatriptan—Ill-defined disorder—Epirubicin—hematologic cancer	8.23e-06	5.09e-05	CcSEcCtD
Sumatriptan—Convulsion—Methotrexate—hematologic cancer	8.21e-06	5.08e-05	CcSEcCtD
Sumatriptan—Vomiting—Etoposide—hematologic cancer	8.21e-06	5.07e-05	CcSEcCtD
Sumatriptan—Erythema—Doxorubicin—hematologic cancer	8.21e-06	5.07e-05	CcSEcCtD
Sumatriptan—Anaemia—Epirubicin—hematologic cancer	8.2e-06	5.07e-05	CcSEcCtD
Sumatriptan—Agitation—Epirubicin—hematologic cancer	8.15e-06	5.04e-05	CcSEcCtD
Sumatriptan—Rash—Etoposide—hematologic cancer	8.14e-06	5.03e-05	CcSEcCtD
Sumatriptan—Dermatitis—Etoposide—hematologic cancer	8.13e-06	5.03e-05	CcSEcCtD
Sumatriptan—Headache—Etoposide—hematologic cancer	8.09e-06	5e-05	CcSEcCtD
Sumatriptan—Flatulence—Doxorubicin—hematologic cancer	8.09e-06	5e-05	CcSEcCtD
Sumatriptan—Chest pain—Methotrexate—hematologic cancer	8.07e-06	4.99e-05	CcSEcCtD
Sumatriptan—Arthralgia—Methotrexate—hematologic cancer	8.07e-06	4.99e-05	CcSEcCtD
Sumatriptan—Myalgia—Methotrexate—hematologic cancer	8.07e-06	4.99e-05	CcSEcCtD
Sumatriptan—Decreased appetite—Prednisone—hematologic cancer	8.05e-06	4.97e-05	CcSEcCtD
Sumatriptan—Dysgeusia—Doxorubicin—hematologic cancer	8.04e-06	4.97e-05	CcSEcCtD
Sumatriptan—Rash—Prednisolone—hematologic cancer	8.03e-06	4.96e-05	CcSEcCtD
Sumatriptan—Dermatitis—Prednisolone—hematologic cancer	8.02e-06	4.96e-05	CcSEcCtD
Sumatriptan—Malaise—Epirubicin—hematologic cancer	8e-06	4.94e-05	CcSEcCtD
Sumatriptan—Fatigue—Prednisone—hematologic cancer	7.98e-06	4.93e-05	CcSEcCtD
Sumatriptan—Headache—Prednisolone—hematologic cancer	7.98e-06	4.93e-05	CcSEcCtD
Sumatriptan—Discomfort—Methotrexate—hematologic cancer	7.97e-06	4.93e-05	CcSEcCtD
Sumatriptan—Vertigo—Epirubicin—hematologic cancer	7.97e-06	4.93e-05	CcSEcCtD
Sumatriptan—Syncope—Epirubicin—hematologic cancer	7.95e-06	4.92e-05	CcSEcCtD
Sumatriptan—Back pain—Doxorubicin—hematologic cancer	7.94e-06	4.91e-05	CcSEcCtD
Sumatriptan—Constipation—Prednisone—hematologic cancer	7.91e-06	4.89e-05	CcSEcCtD
Sumatriptan—Muscle spasms—Doxorubicin—hematologic cancer	7.89e-06	4.88e-05	CcSEcCtD
Sumatriptan—Palpitations—Epirubicin—hematologic cancer	7.84e-06	4.84e-05	CcSEcCtD
Sumatriptan—Confusional state—Methotrexate—hematologic cancer	7.8e-06	4.82e-05	CcSEcCtD
Sumatriptan—Loss of consciousness—Epirubicin—hematologic cancer	7.8e-06	4.82e-05	CcSEcCtD
Sumatriptan—Dizziness—Triamcinolone—hematologic cancer	7.75e-06	4.79e-05	CcSEcCtD
Sumatriptan—Cough—Epirubicin—hematologic cancer	7.74e-06	4.78e-05	CcSEcCtD
Sumatriptan—Anaphylactic shock—Methotrexate—hematologic cancer	7.73e-06	4.78e-05	CcSEcCtD
Sumatriptan—Convulsion—Epirubicin—hematologic cancer	7.68e-06	4.75e-05	CcSEcCtD
Sumatriptan—Infection—Methotrexate—hematologic cancer	7.68e-06	4.75e-05	CcSEcCtD
Sumatriptan—Nausea—Etoposide—hematologic cancer	7.67e-06	4.74e-05	CcSEcCtD
Sumatriptan—Hypertension—Epirubicin—hematologic cancer	7.66e-06	4.73e-05	CcSEcCtD
Sumatriptan—Feeling abnormal—Prednisone—hematologic cancer	7.63e-06	4.71e-05	CcSEcCtD
Sumatriptan—Asthenia—Betamethasone—hematologic cancer	7.62e-06	4.71e-05	CcSEcCtD
Sumatriptan—Asthenia—Dexamethasone—hematologic cancer	7.62e-06	4.71e-05	CcSEcCtD
Sumatriptan—Ill-defined disorder—Doxorubicin—hematologic cancer	7.61e-06	4.71e-05	CcSEcCtD
Sumatriptan—Nervous system disorder—Methotrexate—hematologic cancer	7.59e-06	4.69e-05	CcSEcCtD
Sumatriptan—Anaemia—Doxorubicin—hematologic cancer	7.58e-06	4.69e-05	CcSEcCtD
Sumatriptan—Thrombocytopenia—Methotrexate—hematologic cancer	7.57e-06	4.68e-05	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Prednisone—hematologic cancer	7.57e-06	4.68e-05	CcSEcCtD
Sumatriptan—Nausea—Prednisolone—hematologic cancer	7.57e-06	4.68e-05	CcSEcCtD
Sumatriptan—Myalgia—Epirubicin—hematologic cancer	7.55e-06	4.67e-05	CcSEcCtD
Sumatriptan—Chest pain—Epirubicin—hematologic cancer	7.55e-06	4.67e-05	CcSEcCtD
Sumatriptan—Arthralgia—Epirubicin—hematologic cancer	7.55e-06	4.67e-05	CcSEcCtD
Sumatriptan—Agitation—Doxorubicin—hematologic cancer	7.54e-06	4.66e-05	CcSEcCtD
Sumatriptan—Anxiety—Epirubicin—hematologic cancer	7.52e-06	4.65e-05	CcSEcCtD
Sumatriptan—Pruritus—Betamethasone—hematologic cancer	7.52e-06	4.65e-05	CcSEcCtD
Sumatriptan—Pruritus—Dexamethasone—hematologic cancer	7.52e-06	4.65e-05	CcSEcCtD
Sumatriptan—Skin disorder—Methotrexate—hematologic cancer	7.51e-06	4.64e-05	CcSEcCtD
Sumatriptan—Hyperhidrosis—Methotrexate—hematologic cancer	7.48e-06	4.62e-05	CcSEcCtD
Sumatriptan—Discomfort—Epirubicin—hematologic cancer	7.46e-06	4.61e-05	CcSEcCtD
Sumatriptan—Vomiting—Triamcinolone—hematologic cancer	7.45e-06	4.6e-05	CcSEcCtD
Sumatriptan—Malaise—Doxorubicin—hematologic cancer	7.4e-06	4.57e-05	CcSEcCtD
Sumatriptan—Rash—Triamcinolone—hematologic cancer	7.38e-06	4.56e-05	CcSEcCtD
Sumatriptan—Dry mouth—Epirubicin—hematologic cancer	7.38e-06	4.56e-05	CcSEcCtD
Sumatriptan—Dermatitis—Triamcinolone—hematologic cancer	7.38e-06	4.56e-05	CcSEcCtD
Sumatriptan—Vertigo—Doxorubicin—hematologic cancer	7.37e-06	4.56e-05	CcSEcCtD
Sumatriptan—Syncope—Doxorubicin—hematologic cancer	7.36e-06	4.55e-05	CcSEcCtD
Sumatriptan—Urticaria—Prednisone—hematologic cancer	7.35e-06	4.54e-05	CcSEcCtD
Sumatriptan—Headache—Triamcinolone—hematologic cancer	7.34e-06	4.54e-05	CcSEcCtD
Sumatriptan—Body temperature increased—Prednisone—hematologic cancer	7.32e-06	4.52e-05	CcSEcCtD
Sumatriptan—Abdominal pain—Prednisone—hematologic cancer	7.32e-06	4.52e-05	CcSEcCtD
Sumatriptan—Confusional state—Epirubicin—hematologic cancer	7.3e-06	4.51e-05	CcSEcCtD
Sumatriptan—Diarrhoea—Dexamethasone—hematologic cancer	7.27e-06	4.49e-05	CcSEcCtD
Sumatriptan—Diarrhoea—Betamethasone—hematologic cancer	7.27e-06	4.49e-05	CcSEcCtD
Sumatriptan—Palpitations—Doxorubicin—hematologic cancer	7.25e-06	4.48e-05	CcSEcCtD
Sumatriptan—Anaphylactic shock—Epirubicin—hematologic cancer	7.24e-06	4.47e-05	CcSEcCtD
Sumatriptan—Oedema—Epirubicin—hematologic cancer	7.24e-06	4.47e-05	CcSEcCtD
Sumatriptan—Hypotension—Methotrexate—hematologic cancer	7.23e-06	4.47e-05	CcSEcCtD
Sumatriptan—Loss of consciousness—Doxorubicin—hematologic cancer	7.21e-06	4.46e-05	CcSEcCtD
Sumatriptan—Infection—Epirubicin—hematologic cancer	7.19e-06	4.44e-05	CcSEcCtD
Sumatriptan—Cough—Doxorubicin—hematologic cancer	7.16e-06	4.43e-05	CcSEcCtD
Sumatriptan—Shock—Epirubicin—hematologic cancer	7.12e-06	4.4e-05	CcSEcCtD
Sumatriptan—Convulsion—Doxorubicin—hematologic cancer	7.11e-06	4.39e-05	CcSEcCtD
Sumatriptan—Nervous system disorder—Epirubicin—hematologic cancer	7.1e-06	4.39e-05	CcSEcCtD
Sumatriptan—Thrombocytopenia—Epirubicin—hematologic cancer	7.09e-06	4.38e-05	CcSEcCtD
Sumatriptan—Hypertension—Doxorubicin—hematologic cancer	7.09e-06	4.38e-05	CcSEcCtD
Sumatriptan—Tachycardia—Epirubicin—hematologic cancer	7.06e-06	4.37e-05	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Methotrexate—hematologic cancer	7.05e-06	4.36e-05	CcSEcCtD
Sumatriptan—Skin disorder—Epirubicin—hematologic cancer	7.03e-06	4.35e-05	CcSEcCtD
Sumatriptan—Dizziness—Betamethasone—hematologic cancer	7.03e-06	4.34e-05	CcSEcCtD
Sumatriptan—Dizziness—Dexamethasone—hematologic cancer	7.03e-06	4.34e-05	CcSEcCtD
Sumatriptan—Hyperhidrosis—Epirubicin—hematologic cancer	7e-06	4.33e-05	CcSEcCtD
Sumatriptan—Arthralgia—Doxorubicin—hematologic cancer	6.99e-06	4.32e-05	CcSEcCtD
Sumatriptan—Myalgia—Doxorubicin—hematologic cancer	6.99e-06	4.32e-05	CcSEcCtD
Sumatriptan—Chest pain—Doxorubicin—hematologic cancer	6.99e-06	4.32e-05	CcSEcCtD
Sumatriptan—Anxiety—Doxorubicin—hematologic cancer	6.96e-06	4.3e-05	CcSEcCtD
Sumatriptan—Nausea—Triamcinolone—hematologic cancer	6.96e-06	4.3e-05	CcSEcCtD
Sumatriptan—Paraesthesia—Methotrexate—hematologic cancer	6.95e-06	4.29e-05	CcSEcCtD
Sumatriptan—Discomfort—Doxorubicin—hematologic cancer	6.9e-06	4.27e-05	CcSEcCtD
Sumatriptan—Dyspnoea—Methotrexate—hematologic cancer	6.9e-06	4.26e-05	CcSEcCtD
Sumatriptan—Somnolence—Methotrexate—hematologic cancer	6.88e-06	4.25e-05	CcSEcCtD
Sumatriptan—Dry mouth—Doxorubicin—hematologic cancer	6.83e-06	4.22e-05	CcSEcCtD
Sumatriptan—Hypersensitivity—Prednisone—hematologic cancer	6.82e-06	4.21e-05	CcSEcCtD
Sumatriptan—Hypotension—Epirubicin—hematologic cancer	6.76e-06	4.18e-05	CcSEcCtD
Sumatriptan—Vomiting—Betamethasone—hematologic cancer	6.76e-06	4.18e-05	CcSEcCtD
Sumatriptan—Vomiting—Dexamethasone—hematologic cancer	6.76e-06	4.18e-05	CcSEcCtD
Sumatriptan—Confusional state—Doxorubicin—hematologic cancer	6.75e-06	4.17e-05	CcSEcCtD
Sumatriptan—Decreased appetite—Methotrexate—hematologic cancer	6.72e-06	4.16e-05	CcSEcCtD
Sumatriptan—Rash—Betamethasone—hematologic cancer	6.7e-06	4.14e-05	CcSEcCtD
Sumatriptan—Rash—Dexamethasone—hematologic cancer	6.7e-06	4.14e-05	CcSEcCtD
Sumatriptan—Anaphylactic shock—Doxorubicin—hematologic cancer	6.7e-06	4.14e-05	CcSEcCtD
Sumatriptan—Oedema—Doxorubicin—hematologic cancer	6.7e-06	4.14e-05	CcSEcCtD
Sumatriptan—Dermatitis—Betamethasone—hematologic cancer	6.69e-06	4.14e-05	CcSEcCtD
Sumatriptan—Dermatitis—Dexamethasone—hematologic cancer	6.69e-06	4.14e-05	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.68e-06	4.13e-05	CcSEcCtD
Sumatriptan—Fatigue—Methotrexate—hematologic cancer	6.67e-06	4.12e-05	CcSEcCtD
Sumatriptan—Headache—Dexamethasone—hematologic cancer	6.66e-06	4.12e-05	CcSEcCtD
Sumatriptan—Headache—Betamethasone—hematologic cancer	6.66e-06	4.12e-05	CcSEcCtD
Sumatriptan—Infection—Doxorubicin—hematologic cancer	6.65e-06	4.11e-05	CcSEcCtD
Sumatriptan—Asthenia—Prednisone—hematologic cancer	6.64e-06	4.1e-05	CcSEcCtD
Sumatriptan—Pain—Methotrexate—hematologic cancer	6.61e-06	4.09e-05	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Epirubicin—hematologic cancer	6.59e-06	4.08e-05	CcSEcCtD
Sumatriptan—Shock—Doxorubicin—hematologic cancer	6.59e-06	4.07e-05	CcSEcCtD
Sumatriptan—Nervous system disorder—Doxorubicin—hematologic cancer	6.57e-06	4.06e-05	CcSEcCtD
Sumatriptan—Thrombocytopenia—Doxorubicin—hematologic cancer	6.56e-06	4.05e-05	CcSEcCtD
Sumatriptan—Pruritus—Prednisone—hematologic cancer	6.55e-06	4.05e-05	CcSEcCtD
Sumatriptan—Tachycardia—Doxorubicin—hematologic cancer	6.54e-06	4.04e-05	CcSEcCtD
Sumatriptan—Skin disorder—Doxorubicin—hematologic cancer	6.51e-06	4.02e-05	CcSEcCtD
Sumatriptan—Paraesthesia—Epirubicin—hematologic cancer	6.5e-06	4.02e-05	CcSEcCtD
Sumatriptan—Hyperhidrosis—Doxorubicin—hematologic cancer	6.47e-06	4e-05	CcSEcCtD
Sumatriptan—Dyspnoea—Epirubicin—hematologic cancer	6.45e-06	3.99e-05	CcSEcCtD
Sumatriptan—Somnolence—Epirubicin—hematologic cancer	6.44e-06	3.98e-05	CcSEcCtD
Sumatriptan—Feeling abnormal—Methotrexate—hematologic cancer	6.37e-06	3.94e-05	CcSEcCtD
Sumatriptan—Diarrhoea—Prednisone—hematologic cancer	6.33e-06	3.91e-05	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Methotrexate—hematologic cancer	6.32e-06	3.91e-05	CcSEcCtD
Sumatriptan—Nausea—Dexamethasone—hematologic cancer	6.31e-06	3.9e-05	CcSEcCtD
Sumatriptan—Nausea—Betamethasone—hematologic cancer	6.31e-06	3.9e-05	CcSEcCtD
Sumatriptan—Decreased appetite—Epirubicin—hematologic cancer	6.29e-06	3.89e-05	CcSEcCtD
Sumatriptan—Hypotension—Doxorubicin—hematologic cancer	6.26e-06	3.87e-05	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Epirubicin—hematologic cancer	6.25e-06	3.86e-05	CcSEcCtD
Sumatriptan—Fatigue—Epirubicin—hematologic cancer	6.24e-06	3.86e-05	CcSEcCtD
Sumatriptan—Pain—Epirubicin—hematologic cancer	6.19e-06	3.83e-05	CcSEcCtD
Sumatriptan—Constipation—Epirubicin—hematologic cancer	6.19e-06	3.83e-05	CcSEcCtD
Sumatriptan—Urticaria—Methotrexate—hematologic cancer	6.14e-06	3.8e-05	CcSEcCtD
Sumatriptan—Dizziness—Prednisone—hematologic cancer	6.12e-06	3.78e-05	CcSEcCtD
Sumatriptan—Body temperature increased—Methotrexate—hematologic cancer	6.11e-06	3.78e-05	CcSEcCtD
Sumatriptan—Abdominal pain—Methotrexate—hematologic cancer	6.11e-06	3.78e-05	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	6.1e-06	3.77e-05	CcSEcCtD
Sumatriptan—Paraesthesia—Doxorubicin—hematologic cancer	6.01e-06	3.72e-05	CcSEcCtD
Sumatriptan—Dyspnoea—Doxorubicin—hematologic cancer	5.97e-06	3.69e-05	CcSEcCtD
Sumatriptan—Feeling abnormal—Epirubicin—hematologic cancer	5.96e-06	3.69e-05	CcSEcCtD
Sumatriptan—Somnolence—Doxorubicin—hematologic cancer	5.95e-06	3.68e-05	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Epirubicin—hematologic cancer	5.92e-06	3.66e-05	CcSEcCtD
Sumatriptan—Vomiting—Prednisone—hematologic cancer	5.88e-06	3.64e-05	CcSEcCtD
Sumatriptan—Rash—Prednisone—hematologic cancer	5.84e-06	3.61e-05	CcSEcCtD
Sumatriptan—Dermatitis—Prednisone—hematologic cancer	5.83e-06	3.6e-05	CcSEcCtD
Sumatriptan—Decreased appetite—Doxorubicin—hematologic cancer	5.82e-06	3.6e-05	CcSEcCtD
Sumatriptan—Headache—Prednisone—hematologic cancer	5.8e-06	3.58e-05	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.78e-06	3.57e-05	CcSEcCtD
Sumatriptan—Fatigue—Doxorubicin—hematologic cancer	5.77e-06	3.57e-05	CcSEcCtD
Sumatriptan—Urticaria—Epirubicin—hematologic cancer	5.75e-06	3.55e-05	CcSEcCtD
Sumatriptan—Constipation—Doxorubicin—hematologic cancer	5.73e-06	3.54e-05	CcSEcCtD
Sumatriptan—Pain—Doxorubicin—hematologic cancer	5.73e-06	3.54e-05	CcSEcCtD
Sumatriptan—Body temperature increased—Epirubicin—hematologic cancer	5.72e-06	3.54e-05	CcSEcCtD
Sumatriptan—Abdominal pain—Epirubicin—hematologic cancer	5.72e-06	3.54e-05	CcSEcCtD
Sumatriptan—Hypersensitivity—Methotrexate—hematologic cancer	5.7e-06	3.52e-05	CcSEcCtD
Sumatriptan—Asthenia—Methotrexate—hematologic cancer	5.55e-06	3.43e-05	CcSEcCtD
Sumatriptan—Feeling abnormal—Doxorubicin—hematologic cancer	5.52e-06	3.41e-05	CcSEcCtD
Sumatriptan—Nausea—Prednisone—hematologic cancer	5.5e-06	3.4e-05	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Doxorubicin—hematologic cancer	5.48e-06	3.39e-05	CcSEcCtD
Sumatriptan—Pruritus—Methotrexate—hematologic cancer	5.47e-06	3.38e-05	CcSEcCtD
Sumatriptan—Hypersensitivity—Epirubicin—hematologic cancer	5.33e-06	3.3e-05	CcSEcCtD
Sumatriptan—Urticaria—Doxorubicin—hematologic cancer	5.32e-06	3.29e-05	CcSEcCtD
Sumatriptan—Abdominal pain—Doxorubicin—hematologic cancer	5.29e-06	3.27e-05	CcSEcCtD
Sumatriptan—Body temperature increased—Doxorubicin—hematologic cancer	5.29e-06	3.27e-05	CcSEcCtD
Sumatriptan—Diarrhoea—Methotrexate—hematologic cancer	5.29e-06	3.27e-05	CcSEcCtD
Sumatriptan—Asthenia—Epirubicin—hematologic cancer	5.19e-06	3.21e-05	CcSEcCtD
Sumatriptan—Pruritus—Epirubicin—hematologic cancer	5.12e-06	3.17e-05	CcSEcCtD
Sumatriptan—Dizziness—Methotrexate—hematologic cancer	5.11e-06	3.16e-05	CcSEcCtD
Sumatriptan—Diarrhoea—Epirubicin—hematologic cancer	4.95e-06	3.06e-05	CcSEcCtD
Sumatriptan—Hypersensitivity—Doxorubicin—hematologic cancer	4.93e-06	3.05e-05	CcSEcCtD
Sumatriptan—Vomiting—Methotrexate—hematologic cancer	4.92e-06	3.04e-05	CcSEcCtD
Sumatriptan—Rash—Methotrexate—hematologic cancer	4.88e-06	3.01e-05	CcSEcCtD
Sumatriptan—Dermatitis—Methotrexate—hematologic cancer	4.87e-06	3.01e-05	CcSEcCtD
Sumatriptan—Headache—Methotrexate—hematologic cancer	4.85e-06	3e-05	CcSEcCtD
Sumatriptan—Asthenia—Doxorubicin—hematologic cancer	4.81e-06	2.97e-05	CcSEcCtD
Sumatriptan—Dizziness—Epirubicin—hematologic cancer	4.79e-06	2.96e-05	CcSEcCtD
Sumatriptan—Pruritus—Doxorubicin—hematologic cancer	4.74e-06	2.93e-05	CcSEcCtD
Sumatriptan—Vomiting—Epirubicin—hematologic cancer	4.6e-06	2.84e-05	CcSEcCtD
Sumatriptan—Nausea—Methotrexate—hematologic cancer	4.59e-06	2.84e-05	CcSEcCtD
Sumatriptan—Diarrhoea—Doxorubicin—hematologic cancer	4.58e-06	2.83e-05	CcSEcCtD
Sumatriptan—Rash—Epirubicin—hematologic cancer	4.56e-06	2.82e-05	CcSEcCtD
Sumatriptan—Dermatitis—Epirubicin—hematologic cancer	4.56e-06	2.82e-05	CcSEcCtD
Sumatriptan—Headache—Epirubicin—hematologic cancer	4.53e-06	2.8e-05	CcSEcCtD
Sumatriptan—Dizziness—Doxorubicin—hematologic cancer	4.43e-06	2.74e-05	CcSEcCtD
Sumatriptan—Nausea—Epirubicin—hematologic cancer	4.3e-06	2.66e-05	CcSEcCtD
Sumatriptan—Vomiting—Doxorubicin—hematologic cancer	4.26e-06	2.63e-05	CcSEcCtD
Sumatriptan—Rash—Doxorubicin—hematologic cancer	4.22e-06	2.61e-05	CcSEcCtD
Sumatriptan—Dermatitis—Doxorubicin—hematologic cancer	4.22e-06	2.61e-05	CcSEcCtD
Sumatriptan—Headache—Doxorubicin—hematologic cancer	4.2e-06	2.59e-05	CcSEcCtD
Sumatriptan—Nausea—Doxorubicin—hematologic cancer	3.98e-06	2.46e-05	CcSEcCtD
Sumatriptan—MAOA—Metabolism—PIK3R1—hematologic cancer	2.67e-06	5.6e-05	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—PIK3CA—hematologic cancer	2.67e-06	5.6e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	2.66e-06	5.58e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAP2K1—hematologic cancer	2.66e-06	5.57e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PDGFB—hematologic cancer	2.65e-06	5.55e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CD—hematologic cancer	2.64e-06	5.53e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—KRAS—hematologic cancer	2.64e-06	5.53e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MYC—hematologic cancer	2.64e-06	5.53e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FOXO1—hematologic cancer	2.64e-06	5.53e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL2—hematologic cancer	2.64e-06	5.52e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TGFB1—hematologic cancer	2.63e-06	5.52e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PDGFRB—hematologic cancer	2.63e-06	5.52e-05	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—PIK3CA—hematologic cancer	2.62e-06	5.48e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CD44—hematologic cancer	2.61e-06	5.48e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NQO1—hematologic cancer	2.61e-06	5.48e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	2.61e-06	5.47e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CB—hematologic cancer	2.61e-06	5.46e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PDGFRA—hematologic cancer	2.59e-06	5.43e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TSC2—hematologic cancer	2.59e-06	5.43e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—KRAS—hematologic cancer	2.59e-06	5.42e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PRKCG—hematologic cancer	2.58e-06	5.41e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JAK1—hematologic cancer	2.58e-06	5.41e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—FGF2—hematologic cancer	2.58e-06	5.41e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ALB—hematologic cancer	2.58e-06	5.4e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CREBBP—hematologic cancer	2.55e-06	5.34e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3R1—hematologic cancer	2.55e-06	5.34e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FGF2—hematologic cancer	2.53e-06	5.3e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3R1—hematologic cancer	2.49e-06	5.23e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGFR3—hematologic cancer	2.49e-06	5.22e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—JAK2—hematologic cancer	2.47e-06	5.19e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYCS—hematologic cancer	2.47e-06	5.18e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK14—hematologic cancer	2.47e-06	5.17e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CB—hematologic cancer	2.47e-06	5.17e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	2.47e-06	5.17e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.46e-06	5.15e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—KRAS—hematologic cancer	2.44e-06	5.11e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PIK3CA—hematologic cancer	2.43e-06	5.08e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—JAK2—hematologic cancer	2.42e-06	5.08e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ESR1—hematologic cancer	2.42e-06	5.07e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CD—hematologic cancer	2.42e-06	5.07e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MDM2—hematologic cancer	2.42e-06	5.06e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL2RA—hematologic cancer	2.41e-06	5.05e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL2—hematologic cancer	2.39e-06	5.01e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FN1—hematologic cancer	2.39e-06	5.01e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ALB—hematologic cancer	2.39e-06	5e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TERT—hematologic cancer	2.38e-06	5e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PIK3CA—hematologic cancer	2.38e-06	4.98e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MDM2—hematologic cancer	2.37e-06	4.96e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BAD—hematologic cancer	2.36e-06	4.95e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NFKBIA—hematologic cancer	2.36e-06	4.95e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CB—hematologic cancer	2.35e-06	4.93e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MTOR—hematologic cancer	2.35e-06	4.93e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NOTCH1—hematologic cancer	2.34e-06	4.9e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PDGFB—hematologic cancer	2.33e-06	4.88e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MTOR—hematologic cancer	2.3e-06	4.82e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CB—hematologic cancer	2.3e-06	4.82e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTEN—hematologic cancer	2.3e-06	4.82e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CD80—hematologic cancer	2.29e-06	4.8e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CG—hematologic cancer	2.29e-06	4.79e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KIT—hematologic cancer	2.29e-06	4.79e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—NRAS—hematologic cancer	2.29e-06	4.79e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3R1—hematologic cancer	2.28e-06	4.79e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	2.28e-06	4.77e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TSC2—hematologic cancer	2.27e-06	4.77e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTPN11—hematologic cancer	2.25e-06	4.71e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—HRAS—hematologic cancer	2.24e-06	4.7e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PIK3CA—hematologic cancer	2.24e-06	4.7e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDKN1B—hematologic cancer	2.21e-06	4.62e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—HRAS—hematologic cancer	2.2e-06	4.6e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—EP300—hematologic cancer	2.19e-06	4.6e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—MAPK3—hematologic cancer	2.19e-06	4.59e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGFR3—hematologic cancer	2.19e-06	4.59e-05	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—AKT1—hematologic cancer	2.18e-06	4.57e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTP1—hematologic cancer	2.18e-06	4.57e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CREB1—hematologic cancer	2.18e-06	4.56e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TP53—hematologic cancer	2.17e-06	4.54e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK14—hematologic cancer	2.17e-06	4.54e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CASP3—hematologic cancer	2.16e-06	4.53e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDKN1B—hematologic cancer	2.16e-06	4.53e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL2—hematologic cancer	2.16e-06	4.52e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BRAF—hematologic cancer	2.15e-06	4.51e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—hematologic cancer	2.15e-06	4.5e-05	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—AKT1—hematologic cancer	2.14e-06	4.48e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTEN—hematologic cancer	2.13e-06	4.47e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL2—hematologic cancer	2.13e-06	4.47e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ESR1—hematologic cancer	2.13e-06	4.45e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6R—hematologic cancer	2.12e-06	4.45e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CREBBP—hematologic cancer	2.12e-06	4.45e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CASP3—hematologic cancer	2.12e-06	4.44e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL2—hematologic cancer	2.11e-06	4.43e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CB—hematologic cancer	2.11e-06	4.42e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCND1—hematologic cancer	2.1e-06	4.41e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—hematologic cancer	2.1e-06	4.41e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—JUN—hematologic cancer	2.1e-06	4.4e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FN1—hematologic cancer	2.1e-06	4.4e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NFKBIA—hematologic cancer	2.07e-06	4.35e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BAD—hematologic cancer	2.07e-06	4.35e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HRAS—hematologic cancer	2.07e-06	4.34e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCND1—hematologic cancer	2.06e-06	4.32e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—JUN—hematologic cancer	2.06e-06	4.31e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NOTCH1—hematologic cancer	2.05e-06	4.3e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDKN1A—hematologic cancer	2.04e-06	4.27e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—EP300—hematologic cancer	2.03e-06	4.26e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTEN—hematologic cancer	2.03e-06	4.26e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAP2K1—hematologic cancer	2.02e-06	4.24e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CD80—hematologic cancer	2.01e-06	4.22e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CD—hematologic cancer	2.01e-06	4.22e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CG—hematologic cancer	2.01e-06	4.21e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KIT—hematologic cancer	2.01e-06	4.21e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—NRAS—hematologic cancer	2.01e-06	4.21e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NCOR1—hematologic cancer	2e-06	4.2e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTM1—hematologic cancer	2e-06	4.2e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDKN1A—hematologic cancer	1.99e-06	4.18e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PIK3CA—hematologic cancer	1.99e-06	4.18e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTEN—hematologic cancer	1.99e-06	4.17e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK8—hematologic cancer	1.99e-06	4.16e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—hematologic cancer	1.98e-06	4.16e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—AKT1—hematologic cancer	1.98e-06	4.15e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTPN11—hematologic cancer	1.97e-06	4.14e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—KRAS—hematologic cancer	1.97e-06	4.13e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTEN—hematologic cancer	1.97e-06	4.12e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK8—hematologic cancer	1.95e-06	4.08e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—AKT1—hematologic cancer	1.94e-06	4.07e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EP300—hematologic cancer	1.94e-06	4.06e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGF2—hematologic cancer	1.93e-06	4.04e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—MAPK3—hematologic cancer	1.92e-06	4.03e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CREB1—hematologic cancer	1.91e-06	4.01e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3R1—hematologic cancer	1.9e-06	3.98e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EP300—hematologic cancer	1.9e-06	3.97e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BRAF—hematologic cancer	1.89e-06	3.96e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SRC—hematologic cancer	1.88e-06	3.95e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—EP300—hematologic cancer	1.88e-06	3.93e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL2—hematologic cancer	1.87e-06	3.92e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6R—hematologic cancer	1.87e-06	3.91e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CREBBP—hematologic cancer	1.86e-06	3.9e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—JAK2—hematologic cancer	1.85e-06	3.87e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SRC—hematologic cancer	1.84e-06	3.86e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VEGFA—hematologic cancer	1.83e-06	3.84e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AKT1—hematologic cancer	1.83e-06	3.84e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTEN—hematologic cancer	1.82e-06	3.82e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—STAT3—hematologic cancer	1.82e-06	3.81e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NRAS—hematologic cancer	1.81e-06	3.8e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CA—hematologic cancer	1.81e-06	3.79e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MDM2—hematologic cancer	1.8e-06	3.78e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VEGFA—hematologic cancer	1.8e-06	3.76e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—STAT3—hematologic cancer	1.78e-06	3.73e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAP2K1—hematologic cancer	1.78e-06	3.73e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NRAS—hematologic cancer	1.77e-06	3.72e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MTHFR—hematologic cancer	1.77e-06	3.71e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CD—hematologic cancer	1.77e-06	3.7e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CB—hematologic cancer	1.75e-06	3.67e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MTOR—hematologic cancer	1.75e-06	3.67e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.75e-06	3.67e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—EP300—hematologic cancer	1.74e-06	3.64e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK3—hematologic cancer	1.74e-06	3.64e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—KRAS—hematologic cancer	1.73e-06	3.62e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK3—hematologic cancer	1.7e-06	3.56e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGF2—hematologic cancer	1.69e-06	3.54e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MYC—hematologic cancer	1.69e-06	3.54e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TGFB1—hematologic cancer	1.68e-06	3.53e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HRAS—hematologic cancer	1.67e-06	3.51e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3R1—hematologic cancer	1.67e-06	3.49e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MYC—hematologic cancer	1.65e-06	3.46e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TGFB1—hematologic cancer	1.65e-06	3.46e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN1B—hematologic cancer	1.65e-06	3.45e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—AKT1—hematologic cancer	1.63e-06	3.41e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	1.62e-06	3.4e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JAK2—hematologic cancer	1.62e-06	3.4e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CASP3—hematologic cancer	1.61e-06	3.38e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL2—hematologic cancer	1.61e-06	3.37e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—hematologic cancer	1.6e-06	3.36e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	1.59e-06	3.33e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MDM2—hematologic cancer	1.58e-06	3.32e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCND1—hematologic cancer	1.57e-06	3.29e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—JUN—hematologic cancer	1.57e-06	3.28e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KRAS—hematologic cancer	1.56e-06	3.27e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MTOR—hematologic cancer	1.54e-06	3.23e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	1.54e-06	3.23e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KRAS—hematologic cancer	1.53e-06	3.2e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN1A—hematologic cancer	1.52e-06	3.18e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTEN—hematologic cancer	1.52e-06	3.17e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CA—hematologic cancer	1.5e-06	3.15e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.49e-06	3.12e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK8—hematologic cancer	1.48e-06	3.11e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AKT1—hematologic cancer	1.48e-06	3.1e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HRAS—hematologic cancer	1.47e-06	3.08e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EP300—hematologic cancer	1.44e-06	3.03e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	1.44e-06	3.03e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CA—hematologic cancer	1.43e-06	3e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	1.43e-06	2.99e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CASP3—hematologic cancer	1.42e-06	2.97e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL2—hematologic cancer	1.41e-06	2.96e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—hematologic cancer	1.41e-06	2.95e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SRC—hematologic cancer	1.41e-06	2.94e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CA—hematologic cancer	1.4e-06	2.94e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	1.39e-06	2.91e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TP53—hematologic cancer	1.39e-06	2.9e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CREBBP—hematologic cancer	1.38e-06	2.89e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCND1—hematologic cancer	1.38e-06	2.89e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JUN—hematologic cancer	1.38e-06	2.88e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	1.37e-06	2.87e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TP53—hematologic cancer	1.36e-06	2.84e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—STAT3—hematologic cancer	1.35e-06	2.84e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NRAS—hematologic cancer	1.35e-06	2.83e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	1.33e-06	2.79e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTEN—hematologic cancer	1.33e-06	2.79e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HRAS—hematologic cancer	1.33e-06	2.78e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—AKT1—hematologic cancer	1.33e-06	2.78e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.31e-06	2.74e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK8—hematologic cancer	1.3e-06	2.73e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HRAS—hematologic cancer	1.3e-06	2.72e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AKT1—hematologic cancer	1.3e-06	2.72e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	1.29e-06	2.71e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ALB—hematologic cancer	1.29e-06	2.7e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CA—hematologic cancer	1.28e-06	2.69e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—hematologic cancer	1.27e-06	2.66e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EP300—hematologic cancer	1.27e-06	2.66e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MYC—hematologic cancer	1.26e-06	2.64e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	1.26e-06	2.63e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—hematologic cancer	1.24e-06	2.6e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.23e-06	2.59e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SRC—hematologic cancer	1.23e-06	2.59e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—AKT1—hematologic cancer	1.23e-06	2.57e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VEGFA—hematologic cancer	1.2e-06	2.52e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—STAT3—hematologic cancer	1.19e-06	2.49e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NRAS—hematologic cancer	1.19e-06	2.49e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AKT1—hematologic cancer	1.17e-06	2.45e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KRAS—hematologic cancer	1.16e-06	2.44e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AKT1—hematologic cancer	1.15e-06	2.4e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.14e-06	2.39e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK3—hematologic cancer	1.14e-06	2.38e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AKT1—hematologic cancer	1.13e-06	2.38e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MYC—hematologic cancer	1.11e-06	2.32e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TGFB1—hematologic cancer	1.1e-06	2.31e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	1.07e-06	2.24e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AKT1—hematologic cancer	1.05e-06	2.2e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TP53—hematologic cancer	1.03e-06	2.17e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KRAS—hematologic cancer	1.02e-06	2.14e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HRAS—hematologic cancer	9.89e-07	2.07e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTEN—hematologic cancer	9.85e-07	2.06e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—hematologic cancer	9.46e-07	1.98e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—EP300—hematologic cancer	9.39e-07	1.97e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	9.38e-07	1.97e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TP53—hematologic cancer	9.08e-07	1.9e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKT1—hematologic cancer	8.73e-07	1.83e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HRAS—hematologic cancer	8.68e-07	1.82e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—hematologic cancer	8.31e-07	1.74e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKT1—hematologic cancer	7.67e-07	1.61e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CA—hematologic cancer	6.95e-07	1.46e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AKT1—hematologic cancer	5.68e-07	1.19e-05	CbGpPWpGaD
